ASP Isotopes Inc. is a public company that specializes in the production and supply of isotopes for various applications across multiple industries, including healthcare, nuclear energy, and research. The company focuses on leveraging advanced technologies to create high-purity isotopes that are essential for medical diagnostics and treatment, as well as for scientific research and development. By enhancing the availability and quality of isotopes, ASP Isotopes aims to support innovations in medical imaging and cancer therapies, while also addressing the growing demand for reliable isotope sources in the global market.
Law Offices of Howard G. Smith reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ASP Isotopes Inc. (“ASP Isotopes” or “the Company”) (NASDAQ: ASPI) and certain of its officers.
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against ASP Isotopes, Inc (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired ASP Isotopes securities between October 30, 2024 and November 26, 2024, both dates inclusive (the “Class Period”). Investors have until February 3, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). ASP Isotopes investors have until February 3, 2025 to file a lead plaintiff motion.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) and reminds investors of the February 3, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against ASP Isotopes, Inc (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired ASP Isotopes securities between October 30, 2024 and November 26, 2024, both dates inclusive (the “Class Period”). Investors have until February 3, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). ASP Isotopes investors have until February 3, 2025 to file a lead plaintiff motion.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ASP Isotopes Inc. (“ASP Isotopes” or “the Company”) (NASDAQ: ASPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers and acquirers of ASP Isotopes Inc. (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024, both dates inclusive (the “Class Period”). ASP Isotopes is a development stage advanced materials company focused on the production, enrichment, and sale of isotopes.
The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Corredor v. ASP Isotopes Inc., et al., Case No. 1:24-cv-09253, on behalf of persons and entities that purchased or otherwise acquired ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).
Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Corredor v. ASP Isotopes Inc., et al., Case No. 24-cv-09253, on behalf of persons and entities that purchased or otherwise acquired ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ:ASPI) on behalf of ASP Isotopes stockholders. Our investigation concerns whether ASP Isotopes has violated the federal securities laws and/or engaged in other unlawful business practices.
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ASP Isotopes Inc. (“ASPI” or the “Company”) (NASDAQ: ASPI) investors concerning the Company’s possible violations of the federal securities laws.
Law Offices of Howard G. Smith announces an investigation on behalf of ASP Isotopes Inc. (“ASPI” or the “Company”) (NASDAQ: ASPI) investors concerning the Company’s possible violations of federal securities laws.
WASHINGTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it will host an Investor Access Event in South Africa from January 14-16, 2025.
The Law Offices of Frank R. Cruz announces an investigation of ASP Isotopes Inc. (“ASPI” or the “Company”) (NASDAQ: ASPI) on behalf of investors concerning the Company’s possible violations of federal securities laws.
WASHINGTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today issued the following statement in response to a short seller report published on November 26, 2024 by Fuzzy Panda Research (“Fuzzy Panda”). Fuzzy Panda is a self-proclaimed short seller who stands to realize significant gains if the price of ASP Isotopes’s stock declines.
ASP Isotopes Inc (NASDAQ:ASPI) shares are trading lower on Tuesday. The stock initially moved higher after the company announced it completed construction and started commissioning its Silicon-28 enrichment facility, but reversed course after a short seller issued a bearish report on the stock. Here's what you need to know.
ASP Isotopes Inc (NASDAQ:ASPI) shares are trading higher. The company on Thursday announced a deal to collaborate on an advanced nuclear fuel production facility.
